Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration to Develop Next-Generation Oncology Therapies by Carolyn Helms | Aug 3, 2017 | Portfolio News
Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome for Injection for the Treatment of Adults with Newly-Diagnosed Therapy-Related Acute Myeloid Leukemia (t-AML) or AML with Myelodysplasia-Related Changes (AML-MRC) by Carolyn Helms | Aug 3, 2017 | Portfolio News
Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements by Carolyn Helms | Aug 2, 2017 | Portfolio News
Aptinyx Initiates Phase 2 Clinical Studies Evaluating NYX-2925 in Two Chronic Pain Conditions by Carolyn Helms | Aug 1, 2017 | Portfolio News
Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update by Carolyn Helms | Aug 1, 2017 | Portfolio News
